RadioMedix to distribute ITG isotope generators

Biotechnology firm RadioMedix has received exclusive U.S. distribution rights for radioisotope generators produced by German firm ITG Isotope Technologies Garching.

The agreement covers the marketing and distribution of germanium-68 (Ge-68)/gallium-68 (Ga-68) generators and the iQS Ga-68 labeling module for clinical and research applications in the U.S., RadioMedix said.

In a clinical trial of Ga-68 DOTATATE, the radiotracer affected the early and accurate diagnosis of patients with neuroendocrine tumors and helped gauge their response to therapy, said Dr. Izabela Tworowska, RadioMedix's chief scientific officer, in a statement.

Page 1 of 1240
Next Page